- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1861
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1861 companies
Theragen EtexLtd
Market Cap: ₩109.9b
Engages in the research and development, production, and sale of pharmaceutical products in Korea.
A066700
₩3,015.00
7D
-0.2%
1Y
-22.8%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.4b
Researches, develops, produces, and sells pharmaceutical products in China.
603998
CN¥9.84
7D
-0.1%
1Y
-16.7%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥25.7b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥99.00
7D
7.4%
1Y
80.8%
Guangdong VTR Bio-Tech
Market Cap: CN¥3.8b
Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.
300381
CN¥7.71
7D
-1.7%
1Y
7.8%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥5.1b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥44.95
7D
4.5%
1Y
-11.3%
Ningbo Menovo Pharmaceutical
Market Cap: CN¥3.2b
Research, develops, produces, and sells pharmaceutical products.
603538
CN¥14.20
7D
2.9%
1Y
10.1%
Wuhan Hiteck Biological PharmaLtd
Market Cap: CN¥3.2b
A biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China.
300683
CN¥24.02
7D
2.0%
1Y
-0.2%
Welgene BiotechLtd
Market Cap: NT$496.4m
Provides genetic testing services.
6661
NT$21.20
7D
-0.7%
1Y
-4.9%
Cutia Therapeutics
Market Cap: HK$2.4b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.30
7D
35.4%
1Y
14.0%
Viva Biotech Holdings
Market Cap: HK$3.6b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.66
7D
4.4%
1Y
144.1%
China Regenerative Medicine International
Market Cap: HK$114.1m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.34
7D
-15.0%
1Y
107.3%
AIM Vaccine
Market Cap: HK$4.4b
Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.
6660
HK$4.15
7D
25.4%
1Y
-44.5%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$7.1b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.63
7D
1.9%
1Y
22.3%
Source Natural Foods and Herbal Supplements
Market Cap: ₹1.0b
Manufactures and sells ayurveda, health and dietary supplements, and food products in India.
531398
₹166.90
7D
1.2%
1Y
94.8%
Nectar Lifesciences
Market Cap: ₹5.5b
Manufactures and sells pharmaceutical products in India and internationally.
NECLIFE
₹23.90
7D
0.9%
1Y
-28.3%
Gujarat Terce Laboratories
Market Cap: ₹399.9m
Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.
524314
₹57.91
7D
-1.2%
1Y
5.6%
Bilcare
Market Cap: ₹1.8b
Provides pharmaceutical packaging research solutions in India and internationally.
526853
₹76.72
7D
2.4%
1Y
18.2%
Shilpa Medicare
Market Cap: ₹61.0b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.
530549
₹735.00
7D
2.8%
1Y
45.7%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥19.3b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥16.40
7D
-1.0%
1Y
12.3%
Yuhan
Market Cap: ₩8.1t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩105,000.00
7D
-1.9%
1Y
46.2%
Neurizon Therapeutics
Market Cap: AU$68.9m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.
NUZ
AU$0.14
7D
-10.0%
1Y
-25.0%
BF Biosciences
Market Cap: PK₨15.6b
A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.
BFBIO
PK₨184.90
7D
21.0%
1Y
n/a
Biocure Technology
Market Cap: CA$522.2k
Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.
CURE.X
CA$0.05
7D
0%
1Y
n/a
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.6b
A synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.
2563
HK$4.41
7D
0%
1Y
n/a
Delivra Health Brands
Market Cap: CA$6.3m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.20
7D
-11.1%
1Y
-55.6%